Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Kane, MD
The Zucker Hillside Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pillar Clinical Research
Bentonville, Arkansas, United States
- Woodland Internation Research Group
Little Rock, Arkansas, United States
- Woodland Research Northwest
Rogers, Arkansas, United States
- Celexel Clinical Innovations
Bellflower, California, United States
- Synexus
Cerritos, California, United States
- Proscience Research Group
Culver City, California, United States
- Celexel Cns
Garden Grove, California, United States
- Synergy Research
Lemon Grove, California, United States
- Cenexel Cit Riverside
Riverside, California, United States
- Nrc Research Institute
Santa Ana, California, United States
- Behavioral Clinical Research, Inc.
Hollywood, Florida, United States
- Cenexel Rca
Hollywood, Florida, United States
- Segal Institute for Clinical Research
Miami Lakes, Florida, United States
- Cenexel Acmr
Atlanta, Georgia, United States
- Cenexel Iresearch
Decatur, Georgia, United States
- Pillar Clinical Research
Chicago, Illinois, United States
- Uptown Research Institute
Chicago, Illinois, United States
- Cenexel Cbh
Gaithersburg, Maryland, United States
- Cenexel Hri
Berlin, New Jersey, United States
- Richmond Behavioral Associates
Staten Island, New York, United States
- Midwest Clinical Research Center
Dayton, Ohio, United States
- Neuro-Behavioral Clinical Research
North Canton, Ohio, United States
- Community Clinical Research
Austin, Texas, United States
- Insite Clinical Research
DeSoto, Texas, United States
- Pillar Clinical Research
Richardson, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Nov 2023
- Primary completion
- 4 Dec 2024
- Completion
- 4 Dec 2024
- Last update posted
- 22 Oct 2025
- Registered enrollment
- 359
- Registry id
- NCT06179108
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.